Reata Pharmaceuticals Inc.

RETA | NASDAQ

Price Alert Chart Builder DCF Calculator

$172.36

+$0.04 (+0.02%)

At close: Sep 25, 2023, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

0.02%

(1Y)

Key Statistics

Market Data

Market Cap $6.57B

1D Range

172.32 172.46

52W Range

21.83 172.46

Valuation (TTM)

PE -61.56

PB 75.22

EV/EBITDA -62.49

Valuation (NTM)

Forward PE N/A

Forward PEG -0.38

Price Target $62.67

Cash Flow

FCF Yield -3.8%

SBC Adj. FCF Yield -5.1%

SBC Impact -35.2%

Margins

Gross Margin 100.0%

Operating Margin -243.8%

FCF Margin -1022.6%

Growth (CAGR)

Revenue 3Y | 5Y 16.7% | -17.1%

Dil EPS 3Y | 5Y 39.0% | 7.2%

FCF 3Y | 5Y -20.4% | -6.2%

Returns

ROA -60.6%

ROE 47.2%

ROIC -59.0%

Financial Health

Net Cash

$237.34M

Current Ratio 6.75

Interest Coverage -6.47

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.